Table 1.
Involvement of oncogenes and gatekeeper tumor suppressor genes in genetic instability.
| Oncogene or Tumor suppressor gene | Involvement in tumors | Type of genetic instability associated with dysfunction | Putative mechanism for genetic instability |
|---|---|---|---|
| myc | Overexpression (amplification, translocation, or most often, indirect) | s-CIN | Overreplication (S phase stimulation) |
| ras | Mutation altering the aminoacid sequence Overexpression | s-CIN w-CIN? | Overreplication Control myc activity? Centrosome amplification through cyclin D1 |
| Cyclin D1 | Overexpression (amplification, translocation, or most often, indirect) | s-CIN w-CIN? | Overreplication (S phase stimulation) Centrosome amplification |
| Cyclin E | Overexpression (amplification, or most often, indirect) | s-CIN | Impairment of S phase progression Forcing premature S phase entry under conditions of nucleotide deficiency |
| p53 mutant and p53 wild-type | Mutation altering the aminoacid sequence + overexpression Lack of expression | s-CIN, w-CIN | Overreplication (control of myc ?) Loss of mitotic checkpoint Centrosome amplification Tolerance to aneuploidy |
| APC | Lack of expression (most often) | s-CIN? w-CIN | Control of myc through b-catenin Role in chromosome segregation |
| Rb | Lack of expression (gene inactivation, or most often, indirect) | w-CIN s-CIN? | Forcing premature S phase entry under conditions of nucleotide deficiency Centrosome amplification |
is used when the corresponding type of genetic instability, although predictable, has not been clearly demonstrated